[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368725-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368725-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-single-cell-transcriptomic-clustering-reveals-heterogeneous-cd8-exhausted-t-cell-populations-with-different-immune-checkpoint-inhibitor-responses","Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8+ exhausted T cell populations with different immune checkpoint inhibitor responses","","T lymphocytes are key cells within the non-neoplastic tumor microenvironment, able to both suppress and support tumor growth. A specialized population, CD8+ exhausted T cells, is an actionable therapeutic target, but no universally accepted classification exists. Using single-cell transcriptomic profiling across diverse human (n = 8) and mouse (n = 4) cancers, the study identifies shared subpopulations across tumor types and species and integrates them with published exhausted T cell subsets. A specific cluster (C1) expands after immune checkpoint inhibitor treatment, supporting a framework for interpreting and designing future immune-therapy studies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-single-cell-transcriptomic-clustering-reveals-heterogeneous-cd8-exhausted-t-cell-populations-with-different-immune-checkpoint-inhibitor-responses/368725/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-single-cell-transcriptomic-clustering-reveals-heterogeneous-cd8-exhausted-t-cell-populations-with-different-immune-checkpoint-inhibitor-responses/368725.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is classifying CD8+ exhausted T cells important in cancer?","Question",{"text":63,"@type":64},"CD8+ exhausted T cells are a therapeutic target, but the field lacks a uniformly accepted classification scheme. A clearer model helps interpret how exhausted subsets relate to tumor growth and treatment response.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study generate a classification framework for exhausted CD8+ T cells?",{"text":68,"@type":64},"It leveraged single-cell transcriptomic analysis across multiple human and mouse cancer datasets, identified shared subpopulations, and integrated these with previously described exhausted T cell classifications to build a unified contextual framework.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the relationship between immune checkpoint inhibitor treatment and the identified subpopulation cluster C1?",{"text":72,"@type":64},"Cluster C1 increased following immune checkpoint inhibitor treatment in mice and patients, indicating that specific exhausted T cell subpopulations may track with treatment response.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368725,1790197242,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","ONCOIMMUNOLOGY  \n2025, VOL. 14, NO. 1, 2540504 [https://doi.org/10.1080/2162402X.2025.2540504](https://doi.org/10.1080/2162402X.2025.2540504)  \nPan-cancer single cell transcriptomic clustering reveals heterogeneous CD8+ exhausted T cell populations with different immune checkpoint inhibitor responses  \nRui Mu*, Rasha Barakat *, and David H. Gutmann   \nDepartment of Neurology, Washington University, St. Louis, MO, USA  \nABSTRACT  \nIn most cancers, T lymphocytes comprise an essential cellular component of thenon-neoplastic microenvironment, where they have the capacity to both suppress and support tumor growth. One specialized T lymphocyte population is the CD8+ exhausted T cell, which has been intensely studied as an actionable therapeutic target. Unfortunately, there is currently no uniformly accepted classification scheme for these specialized T cells. To provide a potential model for classifying CD8+ exhausted T cells, we leveraged single cell transcriptomic analysis of a diverse collection of both human (n = 8) and mouse (n = 4) cancers to identify unique subpopulations shared across tumor types and species. By integrating data from both human and mouse cancer studies, as well as previously described CD8+ exhausted T cell subsets, we provide an integrated framework to characterize the heterogeneity of exhausted CD8+ T cells. As such, one of these subpopulations (cluster C1) increases following immune checkpoint inhibitor treatment in the setting of cancer in mice and patients. Taken together, this proposed classification scheme may be useful for the design and interpretation of current and future immune-based therapy studies.  \nARTICLE HISTORY  \nReceived 15 April 2025 Revised 21 July 2025 Accepted 22 July 2025  \nKEYWORDS  \nCancer; CD8+ T cells; exhaustion; immune checkpoint inhibitor; transcriptomics  \nIntroduction  \nInitially identified as a functional state of CD8+ T cells in the setting of chronic infection, 1 CD8+ exhausted T cells were later discovered to represent a targetable immune cell population in cancer.2,3 In this context, effector cytotoxic CD8+ T cells expressing specific receptors (e.g., PD-1, TIGIT) engage with ligands expressed on tumor cells (e.g., PDL1, CD155) to become quiescent (exhausted) . These exhausted CD8+ T cells can be therapeutically reactivated to kill tumor cells by abrogating these ligand/receptor interactions.4 Examples of such immune checkpoint inhibitor (ICI) therapies include ipilimumab (targeting the CTLA4 receptor), nivolumab and pembrolizumab (targeting the PD1 receptor), and tiragolumab (targeting TIGIT receptor interactions) .5 While some of these treatments have shown efficacy in clinical trials, others have been less successful.6 We hypothesize that these responses may reflect the heterogeneity of CD8+ exhausted T cell populations in cancer.  \nTo gain insight into the landscape of CD8+ exhausted T cells in cancer, we leveraged nine single cell RNA sequencing (scRNAseq) datasets representing eight distinct human cancer histotypes. Using this approach, we identified five subpopulations of CD8+ PD1+ (PDCD1-expressing) exhausted T cells common to all eight human cancers, four of which were shared in mice. We then integrated our subpopulations with previously reported exhausted T cell classifications and synthesized these findings into a new contextual framework.  \nCONTACT David H. Gutmann  [gutmannd@wustl.edu](gutmannd@wustl.edu)  Department of Neurology, Washington University School of Medicine, Box 8111, 660 South Euclid Avenue, St. Louis, MO 63110, USA  \n*These authors contributed equally to this work.  \n Supplemental data for this article can be accessed online at [https://doi.org/10.1080/2162402X.2025.2540504](https://doi.org/10.1080/2162402X.2025.2540504) .  \n© 2025 The Author(s) . Published with license by Taylor & Francis Group, LLC.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([http://creativecommons.","cbCaijICo6rqJPFH","https://ap.wps.com/l/cbCaijICo6rqJPFH","pdf",3893370,17,"English","# Introduction\n## Overview of CD8+ exhausted T cells and immune checkpoint inhibitors\n## Study rationale and hypothesis\n## Single-cell RNA-seq data integration\n# Materials and methods\n## Mouse ICI treatments","[{\"question\":\"Why is classifying CD8+ exhausted T cells important in cancer?\",\"answer\":\"CD8+ exhausted T cells are a therapeutic target, but the field lacks a uniformly accepted classification scheme. A clearer model helps interpret how exhausted subsets relate to tumor growth and treatment response.\"},{\"question\":\"How did the study generate a classification framework for exhausted CD8+ T cells?\",\"answer\":\"It leveraged single-cell transcriptomic analysis across multiple human and mouse cancer datasets, identified shared subpopulations, and integrated these with previously described exhausted T cell classifications to build a unified contextual framework.\"},{\"question\":\"What was the relationship between immune checkpoint inhibitor treatment and the identified subpopulation cluster C1?\",\"answer\":\"Cluster C1 increased following immune checkpoint inhibitor treatment in mice and patients, indicating that specific exhausted T cell subpopulations may track with treatment response.\"}]","Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8+ exhausted T cell populations with different immune checkpoint inhibitor responses | PDF",1790178209,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3e659a4d41e62236e6ed2c3082c05f3.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05deab09e98422c0b95ca9435b45f74d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f44d8fc407b0ec228685a9a8dd19b718.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1eaf8e40f55c5172b5022e1d2b6f631.webp",980,1306]